Applied BioCode Corporation
Research Applied BioCode Corporation (6598.TW) on Bullrun: market cap TWD 2.97B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker6598.TW
- ExchangeTW
- CountryCayman Islands
- SectorHealthcare
- IndustryMedical Devices
- CurrencyTWD
- Market capTWD 2.97B
- Financial periodQ2 2026
- RevenueTWD 210.11M
- Net incomeTWD 28.05M
- Free cash flowTWD 22.13M
- Gross margin70.6%
Valuation Snapshot
latest market cap is TWD 2.97B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | TWD 2.97B | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 TWD.
About Applied BioCode Corporation
Applied BioCode Corporation designs, develops, and commercializes multiplex diagnostic testing products in California. Its products include the BioCode MDx 3000 system, an automated molecular diagnostic system that automates the detection steps, PCR amplification, and hybridization and target capture; and the BioCode 2500 analyzer, a system that reads each barcode and quantifies the BMB target using the fluorescence signal intensity.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Applied BioCode Corporation's market cap?
Applied BioCode Corporation's market capitalization is TWD 2.97B.
What does Applied BioCode Corporation do?
Applied BioCode Corporation designs, develops, and commercializes multiplex diagnostic testing products in California. Its products include the BioCode MDx 3000 system, an automated molecular diagnostic system that automates the detection steps, PCR amplification, and hybridization and target capture; and the BioCode 2500 analyzer, a system that reads each barcode and quantifies the BMB target using the fluorescence signal intensity.